Difference between revisions of "Template:Drugs for functional gastrointestinal disorders"
Jump to navigation
Jump to search
imported>Ronhjones m (subst:'ing, replaced: {{·}} → • (48) using AWB) |
imported>Anypodetos m (Simplify markup, replaced: • → • (48) using AWB) |
||
| Line 13: | Line 13: | ||
| group1 = Tertiary<BR>amino group | | group1 = Tertiary<BR>amino group | ||
| − | | list1 = [[Oxyphencyclimine]]& | + | | list1 = [[Oxyphencyclimine]] • [[Camylofin]] • [[Mebeverine]] • [[Trimebutine]] • [[Rociverine]] • [[Dicycloverine]] • [[Dihexyverine]] • [[Difemerine]] • [[Piperidolate]] |
| group2 = [[Quaternary ammonium]]<BR>compounds | | group2 = [[Quaternary ammonium]]<BR>compounds | ||
| − | | list2 = [[Benzilone]]& | + | | list2 = [[Benzilone]] • [[Mepenzolate]] • [[Pipenzolate]] • [[Glycopyrronium]] • [[Oxyphenonium]] • [[Penthienate]] • [[Methantheline]] • [[Propantheline]] • [[Otilonium bromide]] • [[Tridihexethyl]] • [[Isopropamide]] • [[Hexocyclium]] • [[Poldine]] • [[Bevonium]] • [[Diphemanil metilsulfate|Diphemanil]] • [[Tiemonium iodide]] • [[Prifinium bromide]] • [[Timepidium bromide]] • [[Fenpiverinium]] |
}} | }} | ||
| Line 22: | Line 22: | ||
| group2 = [[Phosphodiesterase inhibitor]]s | | group2 = [[Phosphodiesterase inhibitor]]s | ||
| − | | list2 = [[Papaverine]]& | + | | list2 = [[Papaverine]] • [[Drotaverine]] • [[Moxaverine]] |
| group3 = Acting on [[5-HT receptor|serotonin receptor]]s | | group3 = Acting on [[5-HT receptor|serotonin receptor]]s | ||
| − | | list3 = ''[[5-HT3 antagonist|5-HT<sub>3</sub> antagonists]]'' ([[Alosetron]], [[Cilansetron]])& | + | | list3 = ''[[5-HT3 antagonist|5-HT<sub>3</sub> antagonists]]'' ([[Alosetron]], [[Cilansetron]]) • ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonist]]s'' ([[Mosapride]], [[Prucalopride]], [[Tegaserod]]) |
| group4 = Other | | group4 = Other | ||
| − | | list4 = [[Fenpiprane]]& | + | | list4 = [[Fenpiprane]] • [[Diisopromine]] • [[Chlorbenzoxamine]] • [[Pinaverium]] • [[Fenoverine]] • [[Idanpramine]] • [[Proxazole]] • [[Alverine]] • [[Trepibutone]] • [[Isometheptene]] • [[Caroverine]] • [[Phloroglucinol]] • [[Silicones]] • [[Trimethyldiphenylpropylamine]] |
}} | }} | ||
| group2 = [[Deadly nightshade|Belladonna]] and derivatives<BR>([[Muscarinic antagonist|antimuscarinic]]s) | | group2 = [[Deadly nightshade|Belladonna]] and derivatives<BR>([[Muscarinic antagonist|antimuscarinic]]s) | ||
| − | | list2 = ''tertiary amines:'' [[Atropine]]& | + | | list2 = ''tertiary amines:'' [[Atropine]] • [[Hyoscyamine]]<BR> |
| − | ''quaternary ammonium compounds:'' [[Scopolamine]] ([[Butylscopolamine]], [[Methylscopolamine]])& | + | ''quaternary ammonium compounds:'' [[Scopolamine]] ([[Butylscopolamine]], [[Methylscopolamine]]) • [[Methylatropine]] • [[Fentonium]] • [[Cimetropium bromide]] |
| group3 = [[Prokinetic|Propulsive]]s | | group3 = [[Prokinetic|Propulsive]]s | ||
| − | | list3 = ''[[dopamine antagonist|primarily dopamine antagonists]]'' ([[Metoclopramide]]/[[Bromopride]], [[Clebopride]], [[Domperidone]], [[Alizapride]])& | + | | list3 = ''[[dopamine antagonist|primarily dopamine antagonists]]'' ([[Metoclopramide]]/[[Bromopride]], [[Clebopride]], [[Domperidone]], [[Alizapride]]) • ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonist]]s'' ([[Cinitapride]] • [[Cisapride]]) |
| group4 = | | group4 = | ||